Enzymlogic
Contact information
- A. Health Biotechnology
- Areas of activity
- Drug development
- Drug discovery
- Screening
Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery.
We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential.
The insight we provide facilitates the screening of compounds at speed and at scale to iterate medicinal chemistry, understand pharmacokinetics/pharmacodynamics (PK/PD) disconnects and build better models to define therapeutic windows.
Our patented kinetic screening platform delivers rapid, accurate compound-target interaction data (Kd, kon, koff and residence time) with total confidence. Our platform enables improved screening of compounds in early discovery: to iterate medicinal chemistry, understand PK/PD disconnects and build better models to define therapeutic windows.
COVALfinder® has been developed to provide an in-depth understanding of the binding mechanism of reversible and irreversible drugs to iterate medicinal chemistry, understand PK/PD disconnects and build better models to define therapeutic windows
We are interested in enhancing our funding opportunities through programs such as H2020. We believe in collaborations as a win-win option, and thus we offer our broad expertise in enzymology applied to drug discovery to be part of any project focused on PROTACs, kinase or GPCRs targets.
Moreover we are looking for partners that may improve our business strategy getting our products to the global market.